Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Nature Medicine|April 20, 2022
Engineered cellular immunotherapies in cancer and beyondAmanda V Finck, Tatiana Blanchard, Christopher P Roselle, et al.The Journal of Clinical Investigation|June 1, 2026
Autoinflammatory syndromes of STING and TREX1 dysfunctionDebby J Park, Kate M Jones, Jessica B Anderson, et al.Nature Communications|May 10, 2024
The STING agonist IMSA101 enhances chimeric antigen receptor T cell function by inducing IL-18 secretionUgur Uslu, Lijun Sun, Sofia Castelli, et al.Proceedings of the National Academy of Sciences of the United States of America|December 15, 2025
Dual-targeted ping-pong CAR T cells: Leveraging peripheral expansion to improve solid tumor immunotherapyAmanda V Finck, Ziming Wang, Donna Gonzales, et al.Journal of Human Immunity|May 13, 2026
Adult-onset STING-associated vasculopathyThomas R Riley, Jonathan J Kotzin, Debby J Park, et al.Immunity|November 22, 2025
IL-9 signaling redirects CAR T cell fate toward CD8+ memory and CD4+ cycling states, enhancing antitumor efficacySofía Castelli, Wesley V Wilson, Ugur Uslu, et al.Nature Communications|May 10, 2024
Pretreatment with IL-15 and IL-18 rescues natural killer cells from granzyme B-mediated apoptosis after cryopreservationAbdulla Berjis, Deeksha Muthumani, Oscar A Aguilar, et al.Pageof 1